J, S., RR, Y., J, C., YD, L., CH, L., LF, C., . . . MY, Z. (2023). Discovery and characterization of a novel cGAS covalent inhibitor for the treatment of inflammatory bowel disease. Acta pharmacologica Sinica, 44(4), 791. https://doi.org/10.1038/s41401-022-01002-5
Chicago Style (17th ed.) CitationJ, Song, et al. "Discovery and Characterization of a Novel CGAS Covalent Inhibitor for the Treatment of Inflammatory Bowel Disease." Acta Pharmacologica Sinica 44, no. 4 (2023): 791. https://doi.org/10.1038/s41401-022-01002-5.
MLA (9th ed.) CitationJ, Song, et al. "Discovery and Characterization of a Novel CGAS Covalent Inhibitor for the Treatment of Inflammatory Bowel Disease." Acta Pharmacologica Sinica, vol. 44, no. 4, 2023, p. 791, https://doi.org/10.1038/s41401-022-01002-5.